Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study
Status: | Recruiting |
---|---|
Conditions: | Obesity Weight Loss, Neurology, Endocrine, Diabetes, Diabetes |
Therapuetic Areas: | Endocrinology, Neurology |
Healthy: | No |
Age Range: | 12 - 21 |
Updated: | 10/21/2018 |
Start Date: | October 1, 2018 |
End Date: | June 2023 |
Contact: | Susan Gross, MS, RD |
Email: | susan.gross@childrenscolorado.org |
Phone: | 7207776143 |
Type 2 diabetes (T2D) in youth is increasing in prevalence in parallel with the obesity
epidemic. In the US, almost half of patients with renal failure have DKD, and ≥80% have T2D.
Compared to adult-onset T2D, youth with T2D have a more aggressive phenotype with greater
insulin resistance (IR), more rapid β-cell decline and higher prevalence of diabetic kidney
disease (DKD), arguing for separate and dedicated studies in youth-onset T2D. Hyperfiltration
is common in youth with T2D, and predicts progressive DKD. Hyperfiltration may also be
associated with early changes in intrarenal hemodynamic function, including increased renal
plasma flow (RPF) and glomerular pressure. Despite the high prevalence and gravity of DKD in
youth-onset T2D, widely effective therapeutic options are lacking. The investigators'
preliminary data support a strong association between IR and hyperfiltration in youth-onset
T2D, but the pathology contributing to this relationship remains unclear. A better
understanding of the pathophysiology underlying hyperfiltration and its relationship with IR
is critical to inform development of new therapeutics. The investigators' overarching
hypotheses are that: 1) hyperfiltration in youth-onset T2D is associated with changes in
intrarenal hemodynamics, resulting in increased renal oxygen demand, 2) the demand is unmet
by the inefficient fuel profile associated with IR (decreased glucose oxidation and increase
free fatty acid [FFA] oxidation), resulting in renal hypoxia and ultimately renal damage. To
address these hypotheses, the investigators will measure peripheral insulin sensitivity,
adipose insulin sensitivity (FFA suppression), glomerular filtration rate (GFR), RPF, and
renal oxygenation in youth with T2D (n=30), obesity (n=20) and in lean (n=20) controls.
epidemic. In the US, almost half of patients with renal failure have DKD, and ≥80% have T2D.
Compared to adult-onset T2D, youth with T2D have a more aggressive phenotype with greater
insulin resistance (IR), more rapid β-cell decline and higher prevalence of diabetic kidney
disease (DKD), arguing for separate and dedicated studies in youth-onset T2D. Hyperfiltration
is common in youth with T2D, and predicts progressive DKD. Hyperfiltration may also be
associated with early changes in intrarenal hemodynamic function, including increased renal
plasma flow (RPF) and glomerular pressure. Despite the high prevalence and gravity of DKD in
youth-onset T2D, widely effective therapeutic options are lacking. The investigators'
preliminary data support a strong association between IR and hyperfiltration in youth-onset
T2D, but the pathology contributing to this relationship remains unclear. A better
understanding of the pathophysiology underlying hyperfiltration and its relationship with IR
is critical to inform development of new therapeutics. The investigators' overarching
hypotheses are that: 1) hyperfiltration in youth-onset T2D is associated with changes in
intrarenal hemodynamics, resulting in increased renal oxygen demand, 2) the demand is unmet
by the inefficient fuel profile associated with IR (decreased glucose oxidation and increase
free fatty acid [FFA] oxidation), resulting in renal hypoxia and ultimately renal damage. To
address these hypotheses, the investigators will measure peripheral insulin sensitivity,
adipose insulin sensitivity (FFA suppression), glomerular filtration rate (GFR), RPF, and
renal oxygenation in youth with T2D (n=30), obesity (n=20) and in lean (n=20) controls.
Inclusion Criteria:
- Obese youth with and without T2D (≥54 kg) and lean controls
- Age 12-21 years
- Weight <300 lbs., no implanted metal devices
- HbA1c < 11% and no recent diabetic ketoacidosis or hyperosmolar hyperglycemia
- No anemia
- BMI >5th percentile for lean controls
Exclusion Criteria:
- T2D onset (diagnosis) > 18 years of age
- Prepubertal
- eGFR <60ml/min/1.73m2 or creatinine > 1.5mg/dl or history of ACR≥300mg/g
- ACE inhibitors, angiotensin receptor blockers (ARB), diuretics, sodium-glucose
co-transport (SGLT) 2 or 1 blockers, daily NSAIDs or aspirin, sulfonamides, procaine,
thiazosulfone or probenecid.
- Seafood or iodine allergy
- Pregnancy
- MRI scanning contraindications (claustrophobia, implantable devices, >300 lbs)
We found this trial at
1
site
13123 E 16th Ave
Aurora, Colorado 80045
Aurora, Colorado 80045
(720) 777-1234
Principal Investigator: Petter Bjornstad, M.D.
Children's Hospital Colorado At Children's Hospital Colorado, we see more, treat more and heal more...
Click here to add this to my saved trials